RxDoctor Payments Data

Atish Patel, MD

Pain Medicine · Feasterville Trevose, PANPI 1265967103

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (56.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Saluda Medical Americas, Inc. at 57.8% of the total. Reporting peaked in 2024 at $8,974 and has fallen 68.8% since, to $2,798 in 2025. Among pain medicine clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,589in general payments, 2019–2025

Across 295 payments — averaging $59.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Saluda Medical Americas, Inc.$10K
  • Boston Scientific$2K
  • Medtronic$2K
  • Abbott$1K
  • Nevro Corp.$947
  • Spinal Simplicity, LLC$211
  • plus $1K from 19 others

What the payments were for

  • Consulting fees$4,75027%
  • Travel & lodging$2,95517%
  • Food & beverage$9,88456%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,589 in reported general payments places this provider in the 90th percentile of 294 pain medicine providers in Pennsylvania.

See all pain medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$207,884
Medicare patients
299
Services billed
1,647

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin127$2,104
Oxycodone Hcl130$1,700
Celecoxib26$1,384
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen67$1,216
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen48$865
Pregabalin42$540
Tizanidine Hcl60$484
Cephalexin23$379
Morphine Sulfate ErMorphine Sulfate16$212
Tramadol Hcl97$203
Cyclobenzaprine Hcl42$189
Baclofen21$164
Duloxetine Hcl18$163
Methylprednisolone19$108
Mupirocin12$75

Paid to pharmacies, not to this prescriber.

Other pain medicine in Feasterville Trevose

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →